Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceuticals targeting cancer and inflammatory diseases. Its structure enables selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in the development of tyrosine kinase and cyclin-dependent kinase (CDK) inhibitors. Also utilized in medicinal chemistry research for optimizing lead compounds due to its favorable pharmacokinetic properties and ability to improve metabolic stability in drug candidates.